{
    "nct_id": "NCT03685695",
    "official_title": "Life on the Go 2: Evaluating the Effect of Physical Activity of Patients With Recurrent Ovarian Cancer Using State of the Art Activity Tracking Device",
    "inclusion_criteria": "* Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1\n* Have recurrent epithelial ovarian, primary peritoneal or fallopian tube cancer (serous, clear cell, endometrioid or mucinous)\n* Patient is willing to wear activity tracking device at least 70% of the time for the duration of the study (9 months)\n* Patient is getting cancer treatment and surveillance visit at Roswell Park Cancer Institute during the study period\n* Patient is willing to participate in quality of life (QOL) questionnaires and blood and stool collection throughout the study for translational research purposes\n* Has no risk factors for increased risk for exercise related complications assessed by 2017 Physical Activity Readiness Questionnaire for Everyone (PAR-Q+) questionnaire and principal investigator (PI)/cooperative (Co)-PI\n* If positive screening test on 2017 PAR-Q+ questionnaire, medical clearance need to be documented by PI/Co-PI with doctor of medicine (MD) degree and/or primary care physician or cardiologist, if deemed necessary by the PI/Co-PIs prior to starting increased physical activity (PA) portion of the trial\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Patient with serious psychiatric illness (e.g. lifetime bipolar disorder, schizophrenia or other psychosis, serious personality disorder, severe major depressive disorder or recent suicide or psychiatric hospitalization in the previous 12 months)\n* Patients with a life expectancy of less than 6 months\n* Patients may not have any other active malignancy that currently requires treatment with the exception of non-melanoma skin cancer\n* Unwilling or unable to follow protocol requirements",
    "miscellaneous_criteria": ""
}